Follow us on LinkedIn

Further questions

What's your question? Ask it in the discussion forum

Have an answer to the questions below? Post it here or in the forum

LATEST NEWSArm CEO Fears Humans Could Lose Control of AI
Arm CEO Fears Humans Could Lose Control of AI

“The thing I worry about most is humans losing capability” over the machines, said  Rene Haas, Chief Executive Officer of Arm Holdings Plc, when asked what keeps him up at night when he thinks about artificial intelligence. “You need some override, some backdoor, some way that the system…

Stay up-to-date with the latest news - click here
LATEST NEWSKim Jong Un might be one of the few world dictators who has been seen crying
Kim Jong Un might be one of the few world dictators who has been seen crying

North Korean leader Kim Jong Un was seen crying on national television during a speech in which he addressed North Korea's declining birthrate.

Stay up-to-date with the latest news - click here
LATEST NEWSChina, Japan trade blame over confrontation near disputed islands
China, Japan trade blame over confrontation near disputed islands
Stay up-to-date with the latest news - click here
LATEST NEWSMusk poll shows X users want U.S. conspiracy theorist Jones' account back
Musk poll shows X users want U.S. conspiracy theorist Jones' account back
Stay up-to-date with the latest news - click here
LATEST NEWSInnate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Patients With Sézary Syndrome at ASH 2023
Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Patients With Sézary Syndrome at ASH 2023

Results confirm promising clinical activity, durable responses and favorable safety of lacutamab in heavily pretreated post-mogamulizumab Sézary Syndrome patients. Virtual KOL event will be held on Tuesday, December 12, 2023 at 7:00AM PST (4:00PM CET) MARSEILLE, France — Innate Pharma SA (Euronext Paris: IPH; Nasdaq:…

Stay up-to-date with the latest news - click here